Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples